The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
The mechanism of action of MF59 – An innately attractive adjuvant formulation
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular and cellular signatures of human vaccine adjuvants
Mosca, F., Tritto, E., Muzzi, A., Monaci, E., Bagnoli, F., Iavarone, C., O'Hagan, D., Rappuoli, R., & De Gregorio, E. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804699105 · Cited by 492
Self-citationCalabro, S., Tortoli, M., Baudner, B. C., Pacitto, A., Cortese, M., O’Hagan, D. T., De Gregorio, E., Seubert, A., & Wack, A. (2011) · Vaccine · doi:10.1016/j.vaccine.2010.12.090 · Cited by 433
Self-citationSeubert, A., Monaci, E., Pizza, M., O’Hagan, D. T., & Wack, A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.8.5402 · Cited by 430
Self-citationNew adjuvants for human vaccines
Mbow, M. L., De Gregorio, E., Valiante, N. M., & Rappuoli, R. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.04.004 · Cited by 406
Self-citationOil-in-Water Emulsion Adjuvant with Influenza Vaccine in Young Children
Vesikari, T., Knuf, M., Wutzler, P., Karvonen, A., Kieninger-Baum, D., Schmitt, H.-J., Baehner, F., Borkowski, A., Tsai, T. F., & Clemens, R. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1010331 · Cited by 317
MF59 Design and Evaluation of a Safe and Potent Adjuvant for Human Vaccines
Ott, G., Barchfeld, G. L., Chernoff, D., Radhakrishnan, R., van Hoogevest, P., & Van Nest, G. (1995) · Pharmaceutical Biotechnology · doi:10.1007/978-1-4615-1823-5_10 · Cited by 298
Self-citationO’Hagan, D. T. (2007) · Expert Review of Vaccines · doi:10.1586/14760584.6.5.699 · Cited by 282
Self-citationThe path to a successful vaccine adjuvant – ‘The long and winding road’
O’Hagan, D. T., & De Gregorio, E. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.02.009 · Cited by 274
Self-citationKhurana, S., Chearwae, W., Castellino, F., Manischewitz, J., King, L. R., Honorkiewicz, A., Rock, M. T., Edwards, K. M., Del Giudice, G., Rappuoli, R., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000624 · Cited by 268
Galli, G., Hancock, K., Hoschler, K., DeVos, J., Praus, M., Bardelli, M., Malzone, C., Castellino, F., Gentile, C., McNally, T., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903181106 · Cited by 263
Alum adjuvanticity: Unraveling a century old mystery
De Gregorio, E., Tritto, E., & Rappuoli, R. (2008) · European Journal of Immunology · doi:10.1002/eji.200838648 · Cited by 232
Self-citationSchultze, V., D’Agosto, V., Wack, A., Novicki, D., Zorn, J., & Hennig, R. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.03.093 · Cited by 227
Schijns, V. E., & Lavelle, E. C. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.21 · Cited by 211
Wack, A., Baudner, B. C., Hilbert, A. K., Manini, I., Nuti, S., Tavarini, S., Scheffczik, H., Ugozzoli, M., Singh, M., Kazzaz, J., et al. (2008) · Vaccine · doi:10.1016/j.vaccine.2007.11.054 · Cited by 195
Self-citationSeubert, A., Calabro, S., Santini, L., Galli, B., Genovese, A., Valentini, S., Aprea, S., Colaprico, A., D'Oro, U., Giuliani, M. M., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1107941108 · Cited by 191
Self-citationEnhanced Immunogenicity of Seasonal Influenza Vaccines in Young Children Using MF59 Adjuvant
Vesikari, T., Pellegrini, M., Karvonen, A., Groth, N., Borkowski, A., O'Hagan, D. T., & Podda, A. (2009) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31819d6394 · Cited by 190
Self-citationDendritic Cells Internalize Vaccine Adjuvant after Intramuscular Injection
Dupuis, M., Murphy, T. J., Higgins, D., Ugozzoli, M., van Nest, G., Ott, G., & McDonald, D. M. (1998) · Cellular Immunology · doi:10.1006/cimm.1998.1283 · Cited by 185
Self-citationPellegrini, M., Nicolay, U., Lindert, K., Groth, N., & Della Cioppa, G. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.08.101 · Cited by 183
MF59 adjuvant: the best insurance against influenza strain diversity
O’Hagan, D. T., Rappuoli, R., Gregorio, E. D., Tsai, T. F., & Giudice, G. D. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.23 · Cited by 149
Self-citationOtt, G., Barchfeld, G. L., & Nest, G. V. (1995) · Vaccine · doi:10.1016/0264-410x(95)00089-j · Cited by 147
Self-citationImmunization with the adjuvant MF59 induces macrophage trafficking and apoptosis
Dupuis, M., Denis-Mize, K. S., LaBarbara, A., Peters, W., Charo, I. F., McDonald, D. M., & Ott, G. S. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(2001010)31:10<2910::aid-immu2910>3.0.co;2-3 · Cited by 145
Self-citationDistribution of adjuvant MF59 and antigen gD2 after intramuscular injection in mice
Dupuis, M. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00263-7 · Cited by 123
Immune mechanisms of protection: can adjuvants rise to the challenge?
McKee, A. S., MacLeod, M. K. L., Kappler, J. W., & Marrack, P. (2010) · BMC Biology · doi:10.1186/1741-7007-8-37 · Cited by 120
Ellebedy, A. H., Lupfer, C. R., Ghoneim, H. E., DeBeauchamp, J., Kanneganti, T., & Webby, R. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012455108 · Cited by 119
Keitel, W. A., Groth, N., Lattanzi, M., Praus, M., Hilbert, A. K., Borkowski, A., & Tsai, T. F. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.10.019 · Cited by 73
The Influence Of Adjuvant On The Therapeutic Efficacy Of A Recombinant Genital Herpes Vaccine
Burke, R. L., Goldbeck, C., Ng, P., Stanberry, L. R., Ott, G. S., & Nest, G. V. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/170.5.1110 · Cited by 59
Self-citationACCUMULATION OF ANTIBODIES IN THE CENTRAL NERVOUS SYSTEM
Freund, J. (1930) · The Journal of Experimental Medicine · doi:10.1084/jem.51.6.889 · Cited by 52
Kalvodova, L. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.12.062 · Cited by 46
Stephenson, I., Hayden, F. G., Osterhaus, A. D. M. E., Howard, W. A., Pervikov, Y., Palkonyay, L., & Kiény, M.-P. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.03.074 · Cited by 24
Cited by
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
Chaudhary, N., Weissman, D., & Whitehead, K. A. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00283-5 · Cited by 1,555
Key roles of adjuvants in modern vaccines
Reed, S. G., Orr, M. T., & Fox, C. B. (2013) · Nature Medicine · doi:10.1038/nm.3409 · Cited by 1,419
Emerging concepts in the science of vaccine adjuvants
Pulendran, B., S. Arunachalam, P., & O’Hagan, D. T. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00163-y · Cited by 1,385
Self-citationVaccine adjuvants: mechanisms and platforms
Zhao, T., Cai, Y., Jiang, Y., He, X., Wei, Y., Yu, Y., & Tian, X. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01557-7 · Cited by 1,020
Immunosenescence and human vaccine immune responses
Crooke, S. N., Ovsyannikova, I. G., Poland, G. A., & Kennedy, R. B. (2019) · Immunity & Ageing · doi:10.1186/s12979-019-0164-9 · Cited by 530
Metadata
- Authors
- O’Hagan, D. T., Ott, G. S., De Gregorio, E., & Seubert, A.
- Venue
- Vaccine
- Publisher
- Elsevier BV
- Published
- 2012-06
- Volume
- 30
- Issue
- 29
- Pages
- 4341-4348
- ISSN
- 0264-410X (ISSN-L)
- OpenAlex
- W1979195886
- Cited by
- 488
- References
- 29
- FWCI
- 10.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.